Related Experiment Video
Updated: Jul 31, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Turning cancer's metabolic plasticity into fragility- an evolving paradigm
Shanmugasundaram Ganapathy-Kanniappan1
1a The Division of Interventional Radiology, Russell H. Morgan Department of Radiology & Radiological Science , The Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Cancer Biology & Therapy
|May 4, 2018
Summary
Researchers found that blocking mitochondrial pyruvate metabolism forces cancer cells to rely heavily on glycolysis, making them more sensitive to radiation therapy. This metabolic reprogramming offers a novel therapeutic strategy.
Area of Science:
- Cancer Metabolism
- Mitochondrial Respiration
- Glycolysis
Background:
- Cancer cells exhibit metabolic reprogramming to fuel rapid proliferation.
- Targeting cancer metabolism is a promising therapeutic strategy.
- Conventional approaches often focus on inhibiting glycolysis.
Purpose of the Study:
- To investigate the therapeutic potential of exploiting cancer's metabolic plasticity.
- To explore the effects of abrogating mitochondrial pyruvate metabolism on cancer cells.
- To evaluate the efficacy of inducing a "hyperglycolytic" phenotype.
Main Methods:
- The study involved manipulating mitochondrial pyruvate metabolism in cancer cells.
- Researchers induced a "hyperglycolytic" phenotype.
- Mitochondrial capacity was reduced concurrently.
Main Results:
- Abrogation of mitochondrial pyruvate metabolism led to upregulated glycolysis.
- Cancer cells with upregulated glycolysis showed increased sensitivity to radiation.
- This metabolic shift created a vulnerability in cancer cells.
Conclusions:
- Forced upregulation of glycolysis, combined with reduced mitochondrial function, represents a novel therapeutic paradigm.
- This approach turns metabolic plasticity into a targetable vulnerability.
- Further research is needed to explore the opportunities and challenges of this strategy in cancer therapy.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...